Paradoxical responses to modified, all-oral shorter treatment of tuberculosis in non-immunocompromised patients: Cases from Armenia

BackgroundThe previous publications presented paradoxical responses to anti-TB treatment in non-immunocompromised patients. Treatment for extra-pulmonary tuberculosis was associated with the majority of these responses.ObjectivesIn this paper, we present three cases of paradoxical radiological worsening in the HIV-negative patients receiving new modified, all-oral shorter regimens for pulmonary tuberculosis.MethodsThe treatment effectiveness was assessed based on the radiological and bacteriological examinations. Each of the three patients was adherent to treatment.ResultsAnti-TB therapy was effective in all of the cases, evidenced by bacteriological response. After initiation of treatment, the chest X-rays showed increased infiltration in the lungs. The patients continued treatment without adjustments of the shorter regimens. The following chest X-rays revealed positive dynamics. Despite the lack of specific therapeutic interventions to address radiological deterioration, the shorter treatment courses were successful. This means that radiological worsening detected in the middle of shorter treatment does not always indicate that anti-TB chemotherapy is ineffective.ConclusionParadoxical deterioration of chest X-ray findings may happen in HIV-negative patients receiving shorter regimens for rifampicin-resistant pulmonary tuberculosis but this worsening is not a reliable indicator for treatment outcome prediction. Additional therapeutic interventions or modifications of the chemotherapy regimens are not always necessary.

Authors

Institutions

Publication Details

Journal
International Journal of Risk & Safety in Medicine
Published
2025-06-17
DOI
https://doi.org/10.1177/09246479251353401
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Paradoxical responses to modified, all-oral shorter treatment of tuberculosis in non-immunocompromised patients: Cases from Armenia

Hakob Atshemyan, Naira Khachatryan, Narine R. Mirzoyan, Anush Khachatryan et al.
International Journal of Risk & Safety in Medicine
Tuberculosis Research and Epidemiology
article

Paradoxical responses to modified, all-oral shorter treatment of tuberculosis in non-immunocompromised patients: Cases from Armenia

Hakob Atshemyan, Naira Khachatryan, Narine R. Mirzoyan, Anush Khachatryan, Karen Poghosyan
article en

Abstract

BackgroundThe previous publications presented paradoxical responses to anti-TB treatment in non-immunocompromised patients. Treatment for extra-pulmonary tuberculosis was associated with the majority of these responses.ObjectivesIn this paper, we present three cases of paradoxical radiological worsening in the HIV-negative patients receiving new modified, all-oral shorter regimens for pulmonary tuberculosis.MethodsThe treatment effectiveness was assessed based on the radiological and bacteriological examinations. Each of the three patients was adherent to treatment.ResultsAnti-TB therapy was effective in all of the cases, evidenced by bacteriological response. After initiation of treatment, the chest X-rays showed increased infiltration in the lungs. The patients continued treatment without adjustments of the shorter regimens. The following chest X-rays revealed positive dynamics. Despite the lack of specific therapeutic interventions to address radiological deterioration, the shorter treatment courses were successful. This means that radiological worsening detected in the middle of shorter treatment does not always indicate that anti-TB chemotherapy is ineffective.ConclusionParadoxical deterioration of chest X-ray findings may happen in HIV-negative patients receiving shorter regimens for rifampicin-resistant pulmonary tuberculosis but this worsening is not a reliable indicator for treatment outcome prediction. Additional therapeutic interventions or modifications of the chemotherapy regimens are not always necessary.

International Journal of Risk & Safety in MedicineVol. 36(4)
Pulmonary Associates (US), Yerevan State Medical University (AM)
Global Fund to Fight AIDS, Tuberculosis and Malaria
Good health and well-being
Openalex Percentile: Top 82%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.